Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
Status:
RECRUITING
Trial end date:
2026-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of VA combined with HAAG in the induction treatment of newly diagnosed acute myeloid leukemia.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University